α-synuclein: Its biological function and role in neurodegenerative diseases

Journal of Molecular Neuroscience

Volumn 20, Issue 2, 2003, Pages 83-92

  Kaplan, Batia ^a   Ratner, Vladimir ^b   Haas, Elisha ^b  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

synuclein; Alzheimer's disease; Amyloid ; Lewy bodies; Parkinson's disease; Synucleinopathy

Indexed keywords

ALPHA SYNUCLEIN;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; GENE IDENTIFICATION; GENE MUTATION; HUMAN; LEWY BODY; NERVE CELL PLASTICITY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SYNAPSE;

ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; HUMANS; LEWY BODIES; MUTATION; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; PRESYNAPTIC TERMINALS; SENILE PLAQUES; SYNUCLEINS;

EID: 0038279986     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:20:2:83     Document Type: Review

References (93)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Ludenberg D., Ho W. H., Castillo P. E., et al. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25(1), 239-252.
2. Ahn B. H., Rhim H., Kim S. Y., Sung Y. M., Lee M. Y., Choi J. Y., et al. (2002) Alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells. J. Biol. Chem. 277(14), 12334-12342.
3. Alim M. A., Hossain M. S., Arima K., Takeda K., Izumiyama Y., Nakamura M., et al. (2002). Tubulin seeds alpha-synuclein fibril formation. J. Biol. Chem. 277(3), 2112-2117.
4. Arawaka S., Saito H., Murayama S., and Mori H. (1998) Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein. Neurology 51, 887-889.
5. Arima K., Ueda K., Sonohara N., Hirai S., Izumiyama Y., Tonozuka-Uehara H., and Kawai M. (1998) Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res. 808, 93-100.
6. Barbieri S., Hofele K., Wiederhold K.-H., Probst A., Mistl C., Danner S., et al. (2001) Mouse models of α-synucleinopathy and Lewy pathology. Adv. Exp. Med. Biol. 487, 147-167.
7. Clayton D. F. and George Y. M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21, 249-254.
8. Conway K. A., Harper J. D., and Lansbury Jr. P. T. (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318-1320.
9. Crowther R. A., Jakes R., Spillantini M. G., and Goedert M. (1998) Synthetic filaments assembled from C-terminally truncated α-synuclein. FEBS Lett. 436, 309-312.
10. Davidson W. S., Jonas A., Clayton D. F., and George J. M. (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443-9449.
11. Davis R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
12. Duda J. E., Giasson B. I., Chen Q., Gur T. L., Hurtig H. I., Stern M. B., et al. (2000) Widespread nitration of pathological inclusions in neurodegenerative synucleopathies. Am. J. Pathol. 157(5), 1439-1445.
13. Engelender S., Kaminsky Z., Guo X., Sharp A. H., Amaravi R. K., Kleiderlein J. J., et al. (1999) Synphilin-1 associates with alpha synuclein and promotes the formation of cytosolic inclusions. Nat. Genet. 22(1), 110-114.
14. Evin G., Beyreuther K., and Masters C. (1994) Alzheimer's disease amyloid precursor protein (AβPP): proteolytic processing, secretases and βA4 amyloid production. Amyloid: Int. J. Exp. Clin. Invest. 1, 263-280.
15. Feany M. B. and Bender W. W. (2000) A Drosophila model of Parkinson's disease. Nature 404, 394-398.
16. Gai W. P, Li Q. X., Power J. H. T., Pountney D. L., and Blumbergs P. C. (2001) Multiple system atrophy inclusion filaments contain ∼10 nm fibrillar core and multiple C-terminally truncated alpha-synucleins, in Neurotransmitters, Modulators and Receptors, poster session, Australian Neuroscience Society Conference, January 28-31, Brisbane, Australia.
17. George J. M., Jin W. S., Woods D. F., and Clayton D. F. (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15, 361-372.
18. Ghee M., Fournier A., and Mallet J. (2000) Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex. J. Neurochem. 75(5), 2221-2224.
19. Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., et al. (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleopathy lesions. Science 290(5493), 985-989.
20. Gomez-Tortosa E., Gonzalo I., Newell K., Garcia Yebenes J., Vonsattel P., and Hyman B. T. (2002) Patterns of protein nitration in dementia with Lewy bodies and stratonigral degeneration. Acta Neuropathol. (Berl.) 103(5), 495-500.
21. Han H., P. H. Weinreb P. H., and Lansbury, P. T. Jr. (1995) The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative diseases? J. Biol. Chem. 2, 163-169.
22. Harper S. Y. and Lo Grasso P. (2001) Signalling for survival and death in neurons: the role of stress-activated kinases, YNK and p38. Cell Signal 13, 299-310.
23. Hashimoto M., Hsu L. J., Rockenstein E., Takenouchi T., Mallory M., and Masliah E. (2002) α-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J. Biol. Chem. 277(13), 11465-11472.
24. Hashimoto M. and Masliah E. (1999) Alpha-synuclein in Lewy body disese and Alzheimer's disease. Brain Pathol. 9, 707-720.
25. Herdegen T., Skene P., and Bahr M. (1997) The c-Jun transcription factor - bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci. 20, 227-231.
26. Hsu L. J., Mallory M., Xia Y., Veinbergs I.,.Hashimoto M, Yoshimoto M., et al. (1998) Expression pattern of synucleins (non-Aβ component of Alzheimer's disease amyloid precursor protein/α-synuclein) during murine brain development. J. Neurochem. 71, 338-344.
27. Hsu L. J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., et al. (2000) Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157(2), 401-410.
28. Irizarry M. C., Kim T. W., McNamara M., Tanzi R. E., George J. M., Clayton D. F., and Hyman B. T. (1996) Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J. Neuropathol. Exp. Neurol. 55, 889-895.
29. Iwai A. (2000) Properties of NACP/A-synuclein and its role in Alzheimer's disease. Biochim. Biophys. Acta 1502, 95-109.
30. Iwai A., Masliah E., Sundsmo M. P., deTeresa R., Mallory M., Salmon D. P., and Saitoh T. (1996) The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease. Brain Res. 720, 230-234.
31. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H. A. R., and Saitoh T. (1995a) The precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system. Neuron 14, 467-475.
32. Iwai A., Yoshimoto M., Masliah E., and Saitoh T. (1995b) Non-Aβ component of Alzheimer's disease amyloid (NAC) is a myloidogenic. Biochemistry 34, 10139-10145.
33. Iwata A., Miura S., Kanazava I., Sawada M., and Nukina N. (2001) Alpha-synuclein forms a complex with transcription factor Elk-1. J. Neurochem. 77(1), 239-252.
34. Jakes R., Spillantini M. G., and Goedert M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 27-32.
35. Jenco J. M., Rawlingston A., Daniels B., and Morris A. J. (1998) Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synucleins. Biochemistry 37, 4901-4909.
36. Jensen P. H., Hager H., Nielsen M. S., Hojrup P., Gliemann J., and Jakes R. (1999) α-Synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J. Biol. Chem. 274, 25481-25489.
37. Jensen P. H., Hojrup P., Hager H., Nielsen M. S., Jacobsen L., Olesen O. F., et al. (1997) Binding of Aβ to α- and β-synucleins: identification of segments in α-synuclein/NAC precursor that bind Aβ and NAC. Biochem J. 323, 539-546.
38. Jensen P. H., Isalm K., Kenney J., Nielsen M. S., Power J., and Gai W. P. (2000) Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments. J. Biol. Chem. 275, 21500-21507.
39. Kahle P. J., Neumann M., Ozmen L., and Haass C. (2000) Physiology and pathophysiology of alpha-synuclein. Cell culture and transgenic animal models based on a Parkinson's disaese-associated protein. Ann. N.Y. Acad. Sci. 920, 33-41.
40. Kholodilov N. G., Neystat M., Oo T. F., Lo S. E., Larsen K. E., Sulzer D., and Burke R. E. (1999a) Increased expression of rat synuclein in the substantia nigra pars campacta identified by mRNA differential display in a model of developmental target injury. J. Neurochem. 73, 2586-2599.
41. Kholodilov N. G., Oo T. F., and Burke R. E. (1999b) Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine. Neurosci. Lett. 275, 105-108.
42. Kim J. (1997) Evidence that the precursor protein on non-Aβ component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil. Mol. Cells 7, 78-83.
43. Kirik D., Rosenblad C., Burger C., Lundberg C., Johansen T. E., Muzyczka N., et al. (2002) Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostratial system. J. Neurosci. 22(7), 2780-2791.
44. Klein R. L., King M. A., Hamny M. E., and Meyer E. M. (2002) Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Hum. Gene Ther. 15(5), 605-612.
45. Kruger R., Kuhn W. M. T., Woitalla D. D., Graeber M., Kosel S., Przuntek H., et al. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
46. Kuzuhara S., Mori H., Izumiyama N., Yoshimura M., and Ihara Y. (1988) Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol. 75, 345-353.
47. Lashuel H. A., Hartley D., Petre B. M., Walz T., and Lansbury P. T. Jr (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418 (6895), 291.
48. Lee H. J., Choi C., and Lee S. J. (2002) Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277(1), 671-678.
49. Lee M., Hyun D., Haliwell B., and Jenner P. (2001) Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J. Neurochem. 76, 998-1009.
50. Lee S. J., Liyanage U., Bickel P. E., Zia W., Lansbury P.T. Jr., and Kosik K. S. A. (1998) Detergent-insoluble membrane compartment contains Aβ in vivo. Nat. Med. 4, 730-734.
51. Maroteaux L, Campanelli J. T., and Scheller R. H. (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve termini. J. Neurosci. 8, 2804-2815.
52. Maroteaux L. and Scheller R. H. (1991) The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Mol. Brain Res. 11, 335-343.
53. Masliah E., Iwai A., Mallory M., Ueda K., and Saitoh T. (1995) Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Am. J. Pathol. 148, 201-210.
54. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., et al. (2000) Dopaminergic loss and inclusion body formation in a α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269.
55. McLean P. J., Kawamata H., Ribich S., and Hyman B. T. (2000) Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. J. Biol. Chem. 275(12), 8812-8816.
56. Mezey E., Deheijia A., Harta G., Papp M. I., Polymeropoulos M. H., and Brownstein M. J. (1998) Alpha-synuclein in neurodegenerative disorders: murderer or accomplice? Nat. Med. 4, 755-757.
57. Mizuno T., Haass C., Michikawa M., and Yanagisawa K. (1998) Cholesterol-dependent generation of a unique amyloid β-protein from apically missorted amyloid precursor protein in MDCK cells. Biochim. Biophys. Acta 1373, 119-130.
58. Mori F., Inenaga C., Yoshimoto M., Umezu H., Tanaka R., Takahashi H., and Wakabayashi K. (2002) Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells. Acta Neuropathol. (Berl.) 103(2), 145-151.
59. Murphy D. D., Rueter S. M., Trojanowski J. Q., and Lee V. M. (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20(9), 3214-3220.
60. Narhi L., Wood S. J., Steavenson S., Jiang W. U., Wu G. M., Anafi D., et al. (1999) Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J. Biol. Chem. 274, 9843-9846.
61. Ostrerova N., Petrucelli L., Farrer M., Mehta N., Choi P., Hardy J., and Wolozin B. (1999) a-Synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 19, 5782-5791.
62. Paik S. R., Lee J. H., Kim D. H., Chang C. S., and Kim Y. S. (1998) Self-oligomerization of NACP, the precursor of the non-amyloid beta/A4 protein (A beta) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25-35). FEBS Lett. 421, 73-76.
63. Paxinou E., Chen Q., Weisse M., Giasson B. I., Norris E. H., Rueter S. M., et al. (2001) Induction of alpha synuclein aggregation by intracellular nitrative insult. J. Neurosci. 21(20), 8053-8061.
64. Payton J. E., Perrin R. J., Clayton D. F., and George J. M. (2001) Protein-protein interactions of alpha-synuclein in brain homogenates and transfected cells. Brain Res. Mol. Brain Res. 95(1-2), 138-145.
65. Perez R. G., Waymire J. C., Lin E., Liu J. J., Guo F., and Zigmond M. J. (2002) A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 22(8), 3090-3099.
66. Petersen K., Olesen O. F., and Mikkelsen J. D. (1999) Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex. Neuroscience 91(2), 651-659.
67. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
68. Przedborski S., Chen Q., Vila M., Giasson B. I., Djaldatti R., Vukosavic S., et al. (2001) Oxidative post-translation modification of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J. Neurochem. 76(2), 634-640.
69. Ribeiro C. S., Carneiro K., Ross C. A., Menezes J. R., and Engelender S. (2002) Synuclein-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein. J. Biol. Chem. 277(26), 23927-23933.
70. Richfield E. K., Thiruchelvam M. J., Cory-Slechta D. A., Wuertzer C., Gainetdinov R. R., Caron M. G., et al. (2002) Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp. Neurol. 175(1), 35-48.
71. Schmidt M. L., Murray, Lee V. M. Y., Hill W. D., Wertkin A., and Trojanowski J. Q. (1991) Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J. Pathol. 139, 53-65.
72. Sharon R., Goldberg M. S., Bar-Josef I., Betensky R. A., Shen J., and Sekoe D. J. (2001) Alpha-synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc. Natl. Acad. Sci. USA 98(16), 9110-9115.
73. Shibayama-Imazu T., Okahanishi I., Omata K., Nakajo S., Ochiai H., Nakai Y., et al. (1993) Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14). Brain Res. 622(1-2), 17-25.
74. Shin E. C., Cho S. E., Lee D. K., Hur M. W., Paik S. R., Park J. H., and Kim J. (2000) Expression patterns of alpha-synuclein in human hematopoietic cell and in Drosophila at different developmental stages. Mol. Cells 10, 65-70.
75. Souza J. M., Giasson B. I., Chen Q., Lee V. M., and Ischiropoulos H. (2000) Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implications of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleopathies. J. Biol. Chem. 275(24), 18344-18349.
76. Spillantini M. G., Schmidt M. L., Lee V. M. Y., Trojanowski J. Q., Jakes R., and Goedert M. (1997) α-Synuclein in Lewy bodies. Nature 388, 839-840.
77. Surgucheva I., McMahan B., Ahmed F., Tomarev S., Wax M. B., and Surguchev A. (2002) Synucleins in glaucoma: implications of gamma-synuclein in glaucomatous alterations in the optic nerve. J. Neurosci. Res. 68(1), 97-106.
78. Takahishi T., Yamashita H., Nakamura T., Nagano Y., and Nakamura S. (2002) Tyrosine125 of alpha-synuclein plays a critical role for dimerization following nitrative stress. Brain Res. 938(1-2), 73-80.
79. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., and Masliah E. (1998) Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am. J. Pathol. 152, 367-372.
80. Tu P. H., Galvin J. E., Baba M., Giasson B., Tomita T., Leight S., et al. (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann. Neurol. 44, 415-422.
81. Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., et al. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 11282-11286.
82. Uversky V. N., Li J., and Fink A. L. (2001) Evidence for a partially folded intermediate in alpha-synuclein fibril formation. Biol. Chem. 276, 10737-10744.
83. Uversky V. N., Talapatra A., Gillespie J. R., and Fink A. L. (1999) Protein deposits as a molecular basis of amyloidosis. Med. Sci. Monit. 5, 1238-1254.
84. van der Putten H., Wiederhold K-H., Probst A., Barbieri S., Mistl C., Danner S., et al. (2000) Neuropathology of mice expressing human α-synuclein. J. Neurosci. 20, 6021-6029.
85. Volles M. J., and Lansbury Jr. P. T. (2002) Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41(14), 4595-4602.
86. Wakabayashi K., Yoshimoto M., Tsuji S., and Takahashi H. (1998) α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 249, 180-182.
87. Weinreb P. H., Zhen W., Poon A. W., Conway K. A., and Lansbury P. T. Jr. (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709-13715.
88. Withers G. S., George J. M., Banker G. A., and Clayton D. F. (1997) Delayed localization of synelfin (syneuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons. Dev. Brain Res. 99, 87-94.
89. Xia X., Harding T., Weller M., Bieneman A., Uney J. B., and Schulz J. B. (2001) Gene transfer of the YNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 98, 10433-10438.
90. Yankner B. A., Dawes L. R, Fisher S., Villa-Komaroff L., Oster-Granite M. L., and Neve R. L. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-420.
91. Yoshimoto M., Iwai A., Kang D., Otero D. A., Xia Y., and Saitoh T. (1995) NACP, the precursor protein of the non-amyloid βA4 protein (Aβ) component of Alzheimer's disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc. Natl. Acad. Sci. USA 92, 9141-9145.
92. Zhou W., Hulbert M. S., Schaack J., Prasad K. N., and Freed C. R. (2000) Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res. 866(1-2), 33-43.
93. Zhou W., Scaack J., Zawada W. M., and Freed C. R. (2002) Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture. Brain Res. 926(1-2), 42-50.